APOA4: Apolipoprotein A4

A key regulator of lipid metabolism, satiety, and antioxidant defense

Gene Information Card

Symbol APOA4
Full Name Apolipoprotein A4
Gene Type protein-coding
Chromosomal Location 11q23.3
NCBI Gene ID 337 ncbi.nlm.nih.gov/gene/337
Ensembl ID ENSG00000110244
UniProt ID P06727
OMIM ID 107690
HGNC ID 602
Aliases apoA-IV, APOA-IV, Apo-AIV

Description

APOA4 (Apolipoprotein A4) encodes a plasma apolipoprotein primarily synthesized in the small intestine during fat absorption. The protein is a component of chylomicrons and high-density lipoproteins (HDL), playing roles in lipid transport, satiety signaling, and antioxidant activity. It is also involved in glucose homeostasis and inflammation modulation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cardiovascular disease APOA4 modulates HDL metabolism and reverse cholesterol transport; variants may alter lipid profiles and atherosclerosis risk. ClinVar, NCBI
Obesity APOA4 acts as a satiety factor; reduced expression or function may impair appetite regulation. OMIM, NCBI
Type 2 diabetes APOA4 influences insulin sensitivity and glucose metabolism; polymorphisms associated with diabetes risk. NCBI, ClinVar
Hypertriglyceridemia APOA4 is a component of triglyceride-rich lipoproteins; mutations may affect lipid clearance. OMIM, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Small intestine 128.2 High
Liver 3.5 Low
Colon 2.1 Low
Stomach 1.8 Low
Pancreas 0.6 Not detected
Cell Line Expression
Cell Line nTPM Notes
Caco-2 15.2 Intestinal epithelial cell line
HepG2 0.8 Hepatocellular carcinoma cell line
HT-29 2.1 Colorectal adenocarcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.127G>A (p.Glu43Lys) Missense 0.01% Alters protein stability; associated with altered lipid levels
c.374C>T (p.Thr125Met) Missense 0.02% May affect HDL binding; reported in hypertriglyceridemia
c.1A>G (p.Met1Val) Start loss <0.01% Loss of translation initiation; likely loss of function
Mutation functional classification

Loss of Function (LOF)

Start loss mutations (e.g., p.Met1Val) abolish protein production, impairing lipid transport and satiety signaling.

Gain of Function (GOF)

Not well documented; some missense variants may enhance antioxidant activity but evidence is limited.

Dominant Negative (DN)

No dominant-negative mutations reported for APOA4.

Pathways

• HDL-mediated lipid transport (Reactome: R-HSA-8963901)
• Chylomicron assembly and remodeling (Reactome: R-HSA-174800)
• Lipoprotein metabolism (KEGG: hsa04979)

Protein Summary

Apolipoprotein A4 (APOA4) is a 46 kDa protein (376 amino acids) secreted mainly by the small intestine. It circulates as a component of chylomicrons and HDL, facilitating lipid transport and reverse cholesterol transport. APOA4 also acts as a satiety factor in the brain, modulates glucose metabolism, and exhibits antioxidant properties by protecting against lipid peroxidation. Its expression is induced by fat ingestion and regulated by PPARα.

Related Products

Product name Cat.No. Species Gene ID
APOA4 Knockout HEK293 Cell Line EDJ-KQ4067 Human 337 Details Get a Quote
APOA4 Knockout HeLa Cell Line EDJ-KQ52631 Human 337 Details Get a Quote
APOA4 Knockout A-549 Cell Line EDJ-KQ61106 Human 337 Details Get a Quote
APOA4 Knockout HCT 116 Cell Line EDJ-KQ69592 Human 337 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: